Deltex Medical Group PLC
23 December 2004
Deltex Medical Group plc
Deltex Medical Group plc ('the Company'), the AIM listed haemodynamic monitoring
company, announces that it has today issued a total of 394,340 new ordinary
shares of 1p each in the Company to certain non-executive directors at a price
of 261/2 pence per share based on yesterday's closing mid-market price .
The three non executive directors named below have elected to take shares in
lieu of a cash payment as remuneration for their services to the Company.
Accordingly, application has been made for these shares to be admitted to
trading on AIM. The shares rank pari passu with the existing issued shares of
the Company and dealings are expected to commence on 4 January 2005. Following
this additional listing, the number of shares in issue will be 69,477,593.
Following this issue, the director's beneficial interests are as follows:
Name of Director Number of shares Holding of shares % of enlarged issued
issued following issue share capital
Nigel Keen (1) 94,340 3,679,917 5.30%
Dr Edwin Snape (3) 215,094 3,095,019 4.45%
Peter Smedvig (2) 84,906 1,029,384 1.48%
Andy Hill - 42,857 0.06%
Ewan Phillips - 465,714 0.67%
George Flouty - 164,285 0.24%
Total 394,340 8,477,176 12.20%
(1) Includes 589,700 shares held as trustee and executor of Pauline Thomas
Charity Will Trust.
(2) Includes shares held as director of Peder Smedvig Capital AS.
(3) Includes shares held as a director of New England Partners and
For further information, please contact:-
Deltex Medical Group plc 01243 774 837
Nigel Keen, Chairman email@example.com
Andy Hill, Chief Executive firstname.lastname@example.org
Ewan Phillips, Finance Director email@example.com
This information is provided by RNS
The company news service from the London Stock Exchange